Multiomic Health Revenue and Competitors

London, London

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Multiomic Health's estimated annual revenue is currently $2.2M per year.(i)
  • Multiomic Health's estimated revenue per employee is $77,500

Employee Data

  • Multiomic Health has 28 Employees.(i)
  • Multiomic Health grew their employee count by 33% last year.

Multiomic Health's People

NameTitleEmail/Phone
1
Co-Founder & CEOReveal Email/Phone
2
Chief Technology & Data OfficerReveal Email/Phone
3
Chief StaffReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
VP, Study & Partnership OpsReveal Email/Phone
6
Senior BioinformaticianReveal Email/Phone
7
Lead Data ScientistReveal Email/Phone
8
Partnerships and Corporate Devt, Senior AssociateReveal Email/Phone
9
Senior AnalystReveal Email/Phone
10
Lead Computational BiologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M2025%N/AN/A
#2
$14M907%$149MN/A
#3
$1.3M17-26%$9.8MN/A
#4
$2.2M2833%N/AN/A
#5
$2.4M31-9%$66.7MN/A
#6
$1.7M22-4%$3.86MN/A
#7
$1.4M1850%$2.11MN/A
#8
$0.1M10%N/AN/A
#9
$4.6M5937%$130MN/A
#10
$27.9M144-3%N/AN/A
Add Company

What Is Multiomic Health?

Multiomic Health is a data-centric therapeutics venture, writing the latest chapter of the precision medicine story by tackling a global, trillion dollar healthcare problem: metabolic syndrome-related conditions (atherosclerotic cardiovascular disease, type 2 diabetes, chronic kidney disease and non-alcoholic fatty liver). \n\nOur mission is to transform patient health outcomes with precision medicines that go beyond the one-size-fits-all approach currently dominating this disease space. We apply advanced computational systems biology modelling and AI-enabled predictive analytics on deep, standardised patient datasets. These datasets feed into a data lake of thousands of patients, featuring millions of data points per patient accumulated from a wide spectrum of omics, rich clinical phenotyping and various tissue types collected over multiple time points. We use our proprietary MOHSAIC® platform to identify unique patient endotypes, re-position existing drug candidates and discover novel drug targets, leading to breakthrough precision therapeutics for the world’s largest patient population.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$2.2M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M28-10%N/A
#2
$4.3M28-18%N/A
#3
$4.9M28-33%N/A
#4
$3.2M28-10%N/A
#5
$4.1M280%N/A